Single-use systems offer a solution to the challenges inherent in buffer preparation, which can be the cause of bottlenecking in bioprocessing.
Because the manufacturing of biotherapeutics requires large volumes of process liquids, buffer preparation is an important aspect of large-scale biomanufacturing. To address the challenges of buffer preparation and ease bottlenecking, MilliporeSigma developed the BioContinuum Buffer Delivery Platform, a new component to its BioContinuum Platform. BioPharm Internationalspoke with Andrew Bulpin, head of process solutions at MilliporeSigma, about what the company’s buffer delivery platform entails, such as single-use components, and the benefits it offers to biomanufacturers.
Read this article in BioPharm International's Single-Use Systems 2019 eBook.
BioPharm International
eBook: Single-Use Systems 2019
Vol. 32
June 2019
Pages: 14–17
When referring to this article, please cite it as F. Mirasol, "Buffers Benefit from Single-Use Systems," BioPharm International Single-Use SystemseBook (June 2019).
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
AES Clean Technology Launches Next-Generation OSM Utility Solution for Cleanrooms at INTERPHEX 2025
April 2nd 2025Officially launched at INTERPHEX 2025, the Omni ASCENT is a next-generation off-site manufactured vertical utility solution that offers optimized cleanroom flexibility and efficiency.